Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

Stay up to date with the latest Eurovision news, covering everything from artist announcements and song releases to national selections and contest developments. This is your reliable source for ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Vericiguat did not reduce the risk of a composite endpoint of time to cardiovascular death or heart failure (HF) hospitalization among patients with HF and reduced ejection fraction (HFrEF) without ...